InMed Pharmaceuticals
Vancouver
About InMed Pharmaceuticals
InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol ("CBN") in diseases with high unmet medical needs. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines. InMed Pharmaceuticals was established in 1981 in Vancouver, Columbia by Chris Bogart.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $73.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: nasdaq:INM
- Website: inmedpharma.com
- Phone: (604) 669-7207
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/inmed-pharmaceuticals-54695 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.